Guidelines for the diagnosis and treatment of neuroendocrine gastrointestinal tumours. A consensus statement on behalf of the European Neuroendocrine Tumour Society (ENETS).
about
Guidelines for the diagnosis and management of carcinoid tumours. Part 1: the gastrointestinal tract. A statement from a Canadian National Carcinoid Expert GroupRecent developments in imaging of pancreatic neuroendocrine tumorsGastrointestinal neuroendocrine tumors: pancreatic endocrine tumorsWell-differentiated neuroendocrine tumor of the stomach: A rare case at an uncommon site.Everolimus-based combination for the treatment of advanced gastroenteropancreatic neuroendocrine neoplasms (GEP-NENs): biological rationale and critical review of published data.Bevacizumab-based combination therapy for advanced gastroenteropancreatic neuroendocrine neoplasms (GEP-NENs): a systematic review of the literature.Ectopic Cushing' syndrome caused by a neuroendocrine carcinoma of the mesenteryThe surgical management of thyroid cancer.Somatostatin analogues in the treatment of gastroenteropancreatic neuroendocrine tumours, current aspects and new perspectives.Diagnosis and treatment of gastroenteropancreatic neuroendocrine tumors: current data on a prospectively collected, retrospectively analyzed clinical multicenter investigation.Consensus recommendations for the diagnosis and management of well-differentiated gastroenterohepatic neuroendocrine tumours: a revised statement from a Canadian National Expert Group.Post-brushing and fine-needle aspiration biopsy follow-up and treatment options for patients with pancreatobiliary lesions: The Papanicolaou Society of Cytopathology GuidelinesDiagnosis and management of pancreatic neuroendocrine tumor in von Hippel-Lindau disease.Recent standardization of treatment strategy for pancreatic neuroendocrine tumors.Clinicopathological characteristics and prognosis-related factors of resectable pancreatic neuroendocrine tumors: a retrospective study of 104 cases in a single Chinese center.Searching for primaries in patients with neuroendocrine tumors (NET) of unknown primary and clinically suspected NET: Evaluation of Ga-68 DOTATOC PET/CT and In-111 DTPA octreotide SPECT/CTMultimodal management of neuroendocrine liver metastases.NANETS treatment guidelines: well-differentiated neuroendocrine tumors of the stomach and pancreasNetazepide, a gastrin receptor antagonist, normalises tumour biomarkers and causes regression of type 1 gastric neuroendocrine tumours in a nonrandomised trial of patients with chronic atrophic gastritis.Cervical neuroendocrine tumor in a young female with Lynch Syndrome.Clinical significance of protein expression of cyclooxygenase-2 and somatostatin receptors in gastroenteropancreatic neuroendocrine tumorsLong acting octreotide in the treatment of advanced hepatocellular cancer and overexpression of somatostatin receptors: randomized placebo-controlled trial.Mutation-targeted therapy with sunitinib or everolimus in patients with advanced low-grade or intermediate-grade neuroendocrine tumours of the gastrointestinal tract and pancreas with or without cytoreductive surgery: protocol for a phase II clinicaUrinary TIMP-1 and MMP-2 levels detect the presence of pancreatic malignancies.A Single Centre Analysis of Clinical Characteristics and Treatment of Endocrine Pancreatic Tumours.TNM staging of foregut (neuro)endocrine tumors: a consensus proposal including a grading system.Eastern Canadian Gastrointestinal Cancer Consensus Conference 2014.Antitumor effects of somatostatin analogs in neuroendocrine tumors.Nuclear medicine imaging of gastro-entero-pancreatic neuroendocrine tumors. The key role of cellular differentiation and tumor grade: from theory to clinical practice.Enteroendocrine precursors differentiate independently of Wnt and form serotonin expressing adenomas in response to active beta-catenin.The current strategy for managing pancreatic neuroendocrine tumors in multiple endocrine neoplasia type 1.Large-Cell Neuroendocrine Carcinoma of the Esophagus: A Case from Saudi ArabiaDoes the WHO 2010 classification of pancreatic neuroendocrine neoplasms accurately characterize pancreatic neuroendocrine carcinomas?Molecular imaging: what can be used today.Carcinoid syndrome: diagnosis and medical management.A case of metachronous double primary neuroendocrine cancer in pancreas/ileum and uterine cervix.Assessment of the efficacy and toxicity of (131)I-metaiodobenzylguanidine therapy for metastatic neuroendocrine tumoursThe prognostic role of WHO classification, urinary 5-hydroxyindoleacetic acid and liver function tests in metastatic neuroendocrine carcinomas of the gastroenteropancreatic tract.Arterial phase enhancement and body mass index are predictors of response to chemoembolisation for liver metastases of endocrine tumoursEndocrine tumours of the gastrointestinal tract-selected topics.
P2860
Q24674315-3969F486-E33F-4BB2-92C6-7EA4C6B2A923Q27005697-D992C45F-681C-420A-A38E-16128F330FB8Q28290833-19C92D54-0230-4608-A4A3-DF0B526C8E44Q30276310-759B8DD8-6E21-4DA4-A291-873AC9088158Q30884794-32466FAF-E025-4F7E-BD08-CFB55F22565FQ31170918-946B7E32-FB16-44F2-98D1-D3B7530D925FQ33241394-5781025A-61D0-49AC-9EFC-BB01FD1FAE38Q33571926-5AF05BDB-8C60-425B-9F42-5FA2F8239128Q33753449-AFA1A956-C485-4150-B7DB-68F99563A067Q33863393-10212C30-5064-43BD-82C1-06B6D9FAED85Q33894587-627B204B-37CE-42D0-8456-C2167F9E83E7Q34127306-16157EB0-57E2-4058-9088-2FDB8FFBE8D7Q34155027-83C226E1-3F23-4E1F-AF78-12468C65B017Q34155032-3CF1EB54-8184-47E9-8EFC-8E5AA6C19129Q34387994-A5467DA4-E055-4E62-AC0E-918A4831C778Q34503869-426CF812-470F-4372-8533-CE1EBECA86BBQ34528199-262D5BE9-B460-4841-BB1B-F5130710B3A6Q35001777-13DDAA57-F243-4BDC-A905-302BAC4936A9Q35009459-08836C39-7BAC-447F-BC12-FD82EB9488D0Q35019094-14EBFCD7-0349-4279-AC65-839405E9D889Q35340967-AE5607F6-9B34-4C06-96BB-E0FF4BCE05C2Q35621231-8A65A988-BA33-4A96-9E5C-E88F23AE9811Q35640506-CF3FD813-3F0C-46BB-A21A-F87AF651CEC9Q35678051-AD58655A-F327-4C6F-99C1-12B9839F822EQ35763588-5877AF6A-68D2-4A0B-B51D-202BBD03F8E9Q35837124-7D257B9B-D947-427B-A3FF-0EC107DBAAAAQ35934322-B745F2B5-14F9-4723-A1E4-DF231CC0A9EEQ36051476-545582AC-FF5A-43FA-9539-0F9C4702FB6DQ36084862-90287198-B739-454C-AECF-4E47BB398012Q36090168-2352FC1D-2A2B-452B-AF68-80B88633D68BQ36113256-0EB97084-D402-4098-9EF4-4D4A61FE815DQ36291598-4A7F7580-5DAD-48F2-8BFA-7A574C0CD75EQ36300517-833A1EAF-B158-4FC9-9087-A8BD76730E3EQ36345342-4D0706AD-753B-4151-A2CA-C1CF4085AE1FQ36380878-58A2F0A6-9E51-447D-A232-4566141BE473Q36396305-D0DFE048-05A3-4EDF-812A-AF2F3A44B6BBQ36510103-D272C363-94C1-40BA-A972-107F9CFC036BQ36610343-851C061B-C8A2-45E1-9774-64B599D1CE60Q36610557-5030F6FA-5BA9-4C79-BCE6-0292A099E89EQ36699524-E0E777DD-0357-4AE3-BF72-52D91445FD97
P2860
Guidelines for the diagnosis and treatment of neuroendocrine gastrointestinal tumours. A consensus statement on behalf of the European Neuroendocrine Tumour Society (ENETS).
description
2004 nî lūn-bûn
@nan
2004年の論文
@ja
2004年論文
@yue
2004年論文
@zh-hant
2004年論文
@zh-hk
2004年論文
@zh-mo
2004年論文
@zh-tw
2004年论文
@wuu
2004年论文
@zh
2004年论文
@zh-cn
name
Guidelines for the diagnosis a ...... ocrine Tumour Society (ENETS).
@ast
Guidelines for the diagnosis a ...... ocrine Tumour Society (ENETS).
@en
type
label
Guidelines for the diagnosis a ...... ocrine Tumour Society (ENETS).
@ast
Guidelines for the diagnosis a ...... ocrine Tumour Society (ENETS).
@en
prefLabel
Guidelines for the diagnosis a ...... ocrine Tumour Society (ENETS).
@ast
Guidelines for the diagnosis a ...... ocrine Tumour Society (ENETS).
@en
P2093
P356
P1433
P1476
Guidelines for the diagnosis a ...... ocrine Tumour Society (ENETS).
@en
P2093
B Eriksson
B Wiedenmann
E P Krenning
European Neuroendocrine Tumour Society
G Delle Fave
P304
P356
10.1159/000085237
P50
P577
2004-01-01T00:00:00Z